Infectious Diseases

Medicine & Life Sciences

1. Cytomegalovirus 100%
2. maribavir 46%
3. Ganciclovir 40%
4. Mutation 34%
5. Transplant Recipients 34%
6. Infections 29%
7. Phosphotransferases 24%
8. Antiviral Agents 23%
9. Cytomegalovirus Infections 23%
10. arabitol 22%
11. Foscarnet 20%
12. Methicillin-Resistant Staphylococcus aureus 20%
13. Drug Resistance 20%
14. Transplants 19%
15. DNA-Directed DNA Polymerase 18%
16. Candida albicans 18%
17. AIC246 17%
18. Cryptococcus neoformans 14%
19. Pharmaceutical Preparations 14%
20. Viral Drug Resistance 12%
21. Therapeutics 12%
22. Staphylococcal Infections 12%
23. Cidofovir 12%
24. Viruses 12%
25. Codon 11%
26. HIV 10%
27. Toxoplasmosis 10%
28. Genes 10%
29. Toxoplasma 10%
30. terminase 10%
31. Anti-Bacterial Agents 9%
32. Valganciclovir 9%
33. Liver Transplantation 9%
34. Hematologic Neoplasms 9%
35. Hematopoietic Stem Cells 8%
36. In Vitro Techniques 8%
37. Hepacivirus 8%
38. Quinolones 8%
39. Mannitol 8%
40. Neurocysticercosis 8%
41. Serum 8%
42. Sexual and Gender Minorities 8%
43. Candidiasis 8%
44. Tissue Donors 8%
45. Tenofovir 7%
46. cyclopropavir 7%
47. T-Lymphocytes 7%
48. Rifampin 7%
49. Growth 7%
50. Blood Culture 7%
51. Delivery of Health Care 6%
52. Hematopoietic Stem Cell Transplantation 6%
53. Immunocompromised Host 6%
54. Urine 6%
55. Hepatitis C 6%
56. Bacteria 6%
57. Acquired Immunodeficiency Syndrome 6%
58. D-arabinitol dehydrogenase 6%
59. Invasive Fungal Infections 6%
60. Virus Diseases 6%
61. Bacteremia 6%
62. Organ Transplantation 6%
63. Population 5%
64. Exonucleases 5%
65. Candida 5%
66. Urinary Tract Infections 5%
67. DNA 5%
68. Suppuration 5%
69. Clinical Trials 5%
70. Genotype 5%
71. 5-aminopyrazole 5%
72. Pre-Exposure Prophylaxis 5%
73. Leukocytes 5%
74. Incidence 5%
75. Antibodies 5%
76. methylenecyclopropane 5%
77. Veterans 5%
78. Simplexvirus glycoprotein B 5%
79. Vaccines 5%
80. Mycobacterium tuberculosis 5%
81. Nursing Homes 5%
82. Outpatients 5%
83. Creatinine 5%